IIPLA Newsroom Access

Continue with Google to unlock the newsroom.

Use Google SSO for the fastest sign-in experience across IP news, saved access limits, and member-only newsroom features. You can still choose another login method if you prefer.

Continue with GoogleUse another sign-in option
Saturday, May 2, 2026
Sign in with SSO
IIPLA Newsroom

IIPLA News

Daily reporting, analysis, and legal-market coverage across patents, trademarks, copyright, licensing, disputes, and policy.

SectionsHomeBlogMembershipLogin
Browse by region and category
All regionsGlobalUSAIndiaChinaEuropeMiddle EastAfricaSoutheast AsiaLatin AmericaUK
All categoriesPatentsTrademarksCopyrightBrandsLitigationLicensingPolicyAI & IPEnforcementCounterfeitingTrade SecretsDomain / Digital Rights
Zydus Lifesciences Resolves Myrbetriq Patent Litigation with Astellas Through $120 Million Settlement
PatentsUSA

Zydus Lifesciences Resolves Myrbetriq Patent Litigation with Astellas Through $120 Million Settlement

Settlement grants Zydus continued US market access for generic Mirabegron and includes ongoing licensing fees through 2027.

Zydus Lifesciences Limited has finalized a comprehensive settlement with Astellas Pharma Inc., ending all US patent disputes over the bladder drug Myrbetriq (Mirabegron). The agreement requires Zydus to pay $120 million plus ongoing licensing fees until September 2027, allowing the company to continue marketing its ge…

Saturday, May 2, 2026
IIPLA News Desk
Newsroom tools
Newsletters & Digests

Subscribe to IIPLA Newsroom

Get Top 5 IP News Today, weekly editorial roundups, and region-aware updates tailored to your practice.

Choose your regions
Choose your categories
By subscribing, you agree to receive IIPLA newsroom emails. You can update preferences or unsubscribe anytime.
Top 5 IP News Today

Essential reading

Open archive
Most Read

Popular with readers

IP News

Becton Dickinson Sues Baxter Over Infusion Pump Patents

Leading medical technology company Becton Dickinson and Company (BD) has filed a patent infringement lawsuit against Baxter International Inc., claiming that Baxter has unlawfully used BD’s patented technologies in it...

Wednesday, May 14, 2025
IIPLA News Desk
IP Blog

Detailed Information About PCT Filing

Regularly check our site to learn about PCT filing and more crucial ideas. The patent Cooperation Treaty is known as PCT. It is an international agreement that has more than 150 members. Submitting a single PCT applic...

Saturday, August 13, 2022
memonhusen
Latest IP News

Fresh coverage

Zydus Lifesciences Resolves Myrbetriq Patent Litigation with Astellas Through $120 Million Settlement
PatentsUSA

Zydus Lifesciences Resolves Myrbetriq Patent Litigation with Astellas Through $120 Million Settlement

Settlement grants Zydus continued US market access for generic Mirabegron and includes ongoing licensing fees through 2027.

Zydus Lifesciences Limited has finalized a comprehensive settlement with Astellas Pharma Inc., ending all US patent disputes over the bladder drug Myrbetriq (Mirabegron). The agreement requires Zydus to pay $120 million plus ongoing licensing fees until September 2027, allowing the company to continue marketing its ge…

Saturday, May 2, 2026
IIPLA News Desk
Patents

Patents coverage

Explore patents
US Again Flags India on Intellectual Property Rights Protection, Keeps It on Priority Watch List
PatentsIndia

US Again Flags India on Intellectual Property Rights Protection, Keeps It on Priority Watch List

India, May 02 : India has once again been placed on the United States Trade Representative’s (USTR) “Priority Watch List” in its latest annual review of intellectual property righ…

India, May 02 : India has once again been placed on the United States Trade Representative’s (USTR) “Priority Watch List” in its latest annual review of intellectual property rights (IPR) protection and enforcement. The designation places India among six countries identified by the US as having significant concerns re…

Saturday, May 2, 2026
IIPLA News Desk
Zydus Lifesciences Resolves Myrbetriq Patent Litigation with Astellas Through $120 Million Settlement
PatentsUSA

Zydus Lifesciences Resolves Myrbetriq Patent Litigation with Astellas Through $120 Million Settlement

Settlement grants Zydus continued US market access for generic Mirabegron and includes ongoing licensing fees through 2027.

Zydus Lifesciences Limited has finalized a comprehensive settlement with Astellas Pharma Inc., ending all US patent disputes over the bladder drug Myrbetriq (Mirabegron). The agreement requires Zydus to pay $120 million plus ongoing licensing fees until September 2027, allowing the company to continue marketing its ge…

Saturday, May 2, 2026
IIPLA News Desk
NMSU's Arrowhead Center honors innovators at 2026 Intellectual Property Awards
PatentsGlobal

NMSU's Arrowhead Center honors innovators at 2026 Intellectual Property Awards

We use cookies (and equivalent technologies) to collect and analyse information on site's performance and to enable the site to function. Some cookies allow third parties to tailo…

We use cookies (and equivalent technologies) to collect and analyse information on site's performance and to enable the site to function. Some cookies allow third parties to tailor the ads you see when you visit our site and other third party websites. By clicking 'Agree', you agree to these uses of cookies. AGREE Man…

Saturday, May 2, 2026
IIPLA News Desk
Kalyan Deshpande Elevated to Chief Judge of U.S. Patent Trial and Appeal Board
PatentsUSA

Kalyan Deshpande Elevated to Chief Judge of U.S. Patent Trial and Appeal Board

USPTO Director John Squires announces appointment of veteran jurist to lead PTAB in overseeing patent and trademark dispute resolution

Kalyan Deshpande, an Indian American jurist with a longstanding tenure at the Patent Trial and Appeal Board, has been appointed Chief Judge of the PTAB. The appointment, announced by U.S. Patent and Trademark Office Director John Squires, places Deshpande at the helm of the tribunal responsible for adjudicating comple…

Saturday, May 2, 2026
IIPLA News Desk
Trademarks

Trademarks coverage

Explore trademarks
India Remains on U.S. Priority Watch List Over Intellectual Property Concerns
TrademarksGlobal

India Remains on U.S. Priority Watch List Over Intellectual Property Concerns

WASHINGTON — The United States has again placed India on its Priority Watch List for intellectual property concerns, citing persistent enforcement gaps, patent delays and long-run…

WASHINGTON — The United States has again placed India on its Priority Watch List for intellectual property concerns, citing persistent enforcement gaps, patent delays and long-running disputes over protections for pharmaceutical and digital products. The designation was included in the 2026 Special 301 Report released…

Friday, May 1, 2026
IIPLA News Desk
USTR Releases 2026 Special 301 Report on Intellectual Property Protection and Enforcement
TrademarksGlobal

USTR Releases 2026 Special 301 Report on Intellectual Property Protection and Enforcement

April Ambassador Greer Issues Statement on Preferential Duty Access for Whiskey Produced in the United Kingdom USTR Releases 2026 Special 301 Report on Intellectual Property Prote…

April Ambassador Greer Issues Statement on Preferential Duty Access for Whiskey Produced in the United Kingdom USTR Releases 2026 Special 301 Report on Intellectual Property Protection and Enforcement USTR Seeks Public Comment on the Modernization of the African Growth and Opportunity Act Public Hearings Regarding Sec…

Friday, May 1, 2026
IIPLA News Desk
Who Owns ‘Iceman’? George Gervin Challenges Caleb Williams in Trademark Showdown
TrademarksUSA

Trademark Battle Emerges Over 'Iceman' Name Between George Gervin and Caleb Williams

NBA legend George Gervin and NFL rookie Caleb Williams file competing trademark applications for 'Iceman,' with UFC's Chuck Liddell also in the mix.

A dispute over the trademark rights to the nickname 'Iceman' has surfaced between basketball Hall of Famer George Gervin and Chicago Bears quarterback Caleb Williams. Both have filed applications to register the mark for commercial use, but UFC veteran Chuck Liddell's earlier filings could complicate the outcome. The…

Wednesday, April 29, 2026
IIPLA News Desk
US says China has failed to crack down on copyright infringement, IP piracy
TrademarksChina

US says China has failed to crack down on copyright infringement, IP piracy

Washington’s annual Notorious Markets List again accuses major Chinese platforms, including units owned by Alibaba Group, of failing to curb trade of…

Washington’s annual Notorious Markets List again accuses major Chinese platforms, including units owned by Alibaba Group, of failing to curb trade of counterfeit goods Updated list comes as economic ties between the sup…

Wednesday, April 29, 2026
IIPLA News Desk
Copyright

Copyright coverage

Explore copyright
Akerman Expands Intellectual Property Team in New York With Haynes Boone Pair
CopyrightGlobal

Akerman Expands Intellectual Property Team in New York With Haynes Boone Pair

Reporting, and expert analysis of legal technology with a focus onwhat legal departments, law firms, and tech companies need to know

Reporting, and expert analysis of legal technology with a focus onwhat legal departments, law firms, and tech companies need to know The Am Law 100 is the definitive ranking of the 100 largest law firms in the United States.

Saturday, May 2, 2026
IIPLA News Desk